NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $22M | $5.2M | $7.0M | −$2.0M | −$66M | −$27M | $1.5M | $23M | $45M | $18M | $21M | $6.4M | $9.5M | $2.2M | −$492K | $69K | −$2.1M |
| Capital expenditures | $29M | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $7.5M | $2.2M | $3.8M | $2.0M | $2.6M | $897K | $916K |
| Free cash flow | −$7.4M | −$22M | −$34M | −$31M | −$97M | −$91M | −$28M | $3.3M | $30M | $4.3M | $14M | $4.2M | $5.7M | $216K | −$3.1M | −$828K | −$3.0M |
| Stock-based compensation | $36M | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7.0M | $6.4M | $5.4M | $3.5M | $641K | $666K | $645K | $285K | — |
| Free cash flow margin | −1.0% | −3.0% | −5.2% | −5.2% | −19.0% | −18.8% | −6.2% | 0.8% | 11.0% | 1.8% | 6.0% | 4.0% | 6.2% | 0.3% | −4.8% | — | — |